Current Opinion in Endocrinology and Diabetes was launched in 1994, with Obesity being added to the title in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of endocrinology and diabetes are divided into 11 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editor for this issue.
Dr Goldfine received both her undergraduate and medical degrees from the University of Pennsylvania, where she received the University Scholar in Medicine Award for academic achievement. Dr Goldfine completed her internship and residency in internal medicine at the University of Massachusetts Medical School. She moved to the Joslin Diabetes Center in 1989 for fellowship training in endocrinology and metabolism, where she remained for post-doctoral training in insulin signaling in the laboratory of C. Ronald Kahn. At the Joslin, she has continued to perform clinical and translational research, provide medical care for patients with diabetes, and teach. She is now an Associate Professor of Medicine at Harvard Medical School, and the Assistant Director of Clinical Research at the Joslin.
Dr Goldfine has authored, co-authored and collaborated on more than 29 publications in peer-reviewed journals, as well as several book chapters. Her research areas of interest include clinical physiologic, genetic, and molecular determinants of type 2 diabetes and cardiovascular complications.